Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Cevimeline in the Treatment of Xerostomia Secondary to Radiation Therapy for Cancer in the Head and Neck Region

NCT00017511 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.

NCT NCT00017511
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00017511 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Cevimeline in the Treatment of Xerostomia Secondary to Radiation Therapy for Cancer in the Head and Neck Region
Lead sponsor
Daiichi Sankyo
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2001
Completion date
March 31, 2003
Enrollment
Not reported
Sites
71

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer, oral complications, radiation toxicity